O
33
-4
MDLZ
38
2
SYY
45
2
THC
67
2
WBA
53
5
OI
34
6
RSG
62
2
RF
54
3
CAT
59
4
MLM
58
-2
ECL
57
3
TXN
43
-3
MAS
59
3
UNP
48
6
MS
69
3
CNX
75
6
DUK
37
2
HBI
52
2
UNH
55
5
GS
63
11
O
33
-4
MDLZ
38
2
SYY
45
2
THC
67
2
WBA
53
5
OI
34
6
RSG
62
2
RF
54
3
CAT
59
4
MLM
58
-2
ECL
57
3
TXN
43
-3
MAS
59
3
UNP
48
6
MS
69
3
CNX
75
6
DUK
37
2
HBI
52
2
UNH
55
5
GS
63
11
Financhill
Back

Haemonetics Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
54

HAE
Haemonetics

Last Price:
74.94
Seasonality Move:
4.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Haemonetics Price Quote

$74.94
-0.04 (1.92%)
(Updated: November 6, 2024 at 5:13 AM ET)

Haemonetics Key Stats

Buy
54
Haemonetics (HAE) is a Buy
Day range:
$73.22 - $75.10
52-week range:
$70.25 - $97.97
Dividend yield:
0%
P/E ratio:
32.74
P/S ratio:
2.89
P/B ratio:
4.24%
Volume:
731K
Avg. volume:
534.2K
1-year change:
-15.21%
Market cap:
$3.8B
Revenue:
$1.3B
EPS:
$2.23

How Much Does Haemonetics Make?

  • How Much Are Haemonetics's Sales Annually?
    HAE Revenues are $1.3B
  • How Much Profit Does Haemonetics's Make A Year?
    HAE net income is $117.6M

Is Haemonetics Growing As A Company?

  • What Is Haemonetics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.08%
  • What Is Haemonetics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.08%

Haemonetics Stock Price Performance

  • Did Haemonetics Stock Go Up Last Month?
    Haemonetics share price went down by -3.74% last month
  • Did HAE's Share Price Rise Over The Last Year?
    HAE share price fell by -15.21% over the past 1 year

What Is Haemonetics 52-Week High & Low?

  • What Is Haemonetics’s 52-Week High Share Price?
    Haemonetics has traded as high as $97.97 over the past 52 weeks
  • What Is Haemonetics’s 52-Week Low Share Price?
    Haemonetics has traded as low as $70.25 over the past 52 weeks

Haemonetics Price To Free Cash Flow

Is It Risky To Buy Haemonetics?

  • How Much Debt Does Haemonetics Have?
    Total long term debt quarterly is $1.2B
  • How Much Cash Does Haemonetics Have?
    Cash and short term investments quarterly total is $344.4M
  • What Is Haemonetics’s Book Value Per Share?
    Book value per share is 17.70

Is Haemonetics Cash Flow Positive?

  • What Is HAE Cash Flow From Operations?
    Cash flow from operations (TTM) is $135.2M
  • What Is Haemonetics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $372.4M
  • What Is Haemonetics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$446.3M

Haemonetics Return On Invested Capital

  • Is Management Doing A Good Job?
    HAE return on invested capital is 6.39%
  • What Is Haemonetics Return On Assets?
    ROA measures how assets are converting to revenues and is 5.27%
  • What Is HAE Return On Equity?
    ROE is a measure of profitability and is 12.58%

Haemonetics Earnings Date & Stock Price

  • What Is Haemonetics's Stock Price Today?
    A single share of HAE can be purchased today for 74.98
  • What Is Haemonetics’s Stock Symbol?
    Haemonetics trades on the nyse under the ticker symbol: HAE
  • When Is Haemonetics’s Next Earnings Date?
    The next quarterly earnings date for Haemonetics is scheduled on November 7, 2024
  • When Is HAE's next ex-dividend date?
    Haemonetics's next ex-dividend date is November 6, 2024
  • How To Buy Haemonetics Stock?
    You can buy Haemonetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Haemonetics Competitors

  • Who Are Haemonetics's Competitors?
    Below is a list of companies who compete with Haemonetics or are related in some way:
    • Baxter International Inc (BAX)
    • Boston Scientific Corp (BSX)
    • Cerus Corp (CERS)
    • Insulet Corp (PODD)
    • Teleflex Inc (TFX)

Haemonetics Dividend Yield

Haemonetics Analyst Estimates

YoY Growth Past Surprise
EPS: -7.5% 1.44%
Revenue: 7.98% 0.34%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 109.80
Upside from Last Price: 46.44%

Major Shareholders

  • How many HAE shares are owned by institutional investors?
    93.1M HAE shares are owned by institutional investors
  • How many HAE shares are owned by insiders?
    1.4M HAE shares are owned by insiders